Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Modelling the genital herpes epidemic.

Blower S.

Herpes. 2004 Aug;11 Suppl 3:138A-146A. Review.

PMID:
15319083
2.

Reducing the risk of transmitting genital herpes: advances in understanding and therapy.

Leone P.

Curr Med Res Opin. 2005 Oct;21(10):1577-82. Review.

PMID:
16238897
3.

Effectiveness and efficiency of imperfect therapeutic HSV-2 vaccines.

Schwartz EJ, Bodine EN, Blower S.

Hum Vaccin. 2007 Nov-Dec;3(6):231-8.

PMID:
17881889
4.

Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemics.

Blower S, Wald A, Gershengorn H, Wang F, Corey L.

J Infect Dis. 2004 Nov 1;190(9):1610-7. Epub 2004 Sep 30.

PMID:
15478066
5.

Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States.

Fisman DN, Lipsitch M, Hook EW 3rd, Goldie SJ.

Sex Transm Dis. 2002 Oct;29(10):608-22.

PMID:
12370529
6.

An update on short-course episodic and prevention therapies for herpes genitalis.

Corey L, Bodsworth N, Mindel A, Patel R, Schacker T, Stanberry L.

Herpes. 2007 Jun;14 Suppl 1:5A-11A. Review.

PMID:
17877886
7.

Predicting the potential individual- and population-level effects of imperfect herpes simplex virus type 2 vaccines.

Schwartz EJ, Blower S.

J Infect Dis. 2005 May 15;191(10):1734-46. Epub 2005 Apr 13.

PMID:
15838802
8.
9.

Prevention of herpes simplex virus type 2 transmission with antiviral therapy.

Corey L, Ashley R; Valaciclovir HSV Transmission Study Group.

Herpes. 2004 Aug;11 Suppl 3:170A-174A. Review.

PMID:
15319087
10.

Management of herpes simplex virus type 2 infection in HIV type 1-infected persons.

Strick LB, Wald A, Celum C.

Clin Infect Dis. 2006 Aug 1;43(3):347-56. Epub 2006 Jun 15.

PMID:
16804851
11.

Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection.

Lingappa JR, Celum C.

Drugs. 2007;67(2):155-74. Review. Erratum in: Drugs. 2007;67(8):1147.

PMID:
17284082
12.

Genital herpes in adolescents.

Auslander BA, Biro FM, Rosenthal SL.

Semin Pediatr Infect Dis. 2005 Jan;16(1):24-30. Review.

PMID:
15685146
13.

HSV shedding.

Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ.

Antiviral Res. 2004 Aug;63 Suppl 1:S19-26. Review.

PMID:
15450382
14.

Genital herpes: natural history and treatment of acute episodes.

Kinghorn GR.

J Med Virol. 1993;Suppl 1:33-8. Review.

PMID:
8245890
16.

Predicting and preventing the emergence of antiviral drug resistance in HSV-2.

Blower SM, Porco TC, Darby G.

Nat Med. 1998 Jun;4(6):673-8.

PMID:
9623975
17.

Developments in STD/HIV interactions: the intertwining epidemics of HIV and HSV-2.

Reynolds SJ, Quinn TC.

Infect Dis Clin North Am. 2005 Jun;19(2):415-25. Review.

PMID:
15963880
18.

Rise in seroprevalence of herpes simplex virus type 1 among highly sexual active homosexual men and an increasing association between herpes simplex virus type 2 and HIV over time (1984-2003).

Smit C, Pfrommer C, Mindel A, Taylor J, Spaargaren J, Berkhout B, Coutinho R, Dukers NH.

Eur J Epidemiol. 2007;22(12):937-44. Epub 2007 Oct 10.

19.

Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?

Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ.

Antiviral Res. 2004 Aug;63 Suppl 1:S3-9. Review.

PMID:
15450380
20.

The psychosocial impact of testing individuals with no history of genital herpes for herpes simplex virus type 2.

Miyai T, Turner KR, Kent CK, Klausner J.

Sex Transm Dis. 2004 Sep;31(9):517-21.

PMID:
15480111

Supplemental Content

Support Center